The cure for coronavirus was found in Israel by Pluristem Therapeutics Inc.,a biotech company in Haifa.
According to Information Drillers, The Israeli coronavirus drug reportedly with a 100% success rate even among severely ill patients is being tested in the United States for the first time.
An Israeli Biotech company located in Haifa, Pluristem Therapeutics Inc., reported that seven patients who were at a high risk of death due to respiratory failure, multi-system organ failure, including heart and kidney failure survived after receiving this medication.
The seven patients were treated with Pluristem’s allogeneic placental expanded (PLX) cells. Essentially, these cells can potentially suppress or reverse the dangerous over-activation of the immune system that causes death in many coronavirus patients.
A critical COVID-19 patient in the US has been treated with the medication, PLX cell therapy, at Holy Name Medical Center in New Jersey. The results of the treatment is yet to be released.